Amer F Alsoudi, Karen M Wai, Euna Koo, Ryan A McConnell, Nathan H Pham, Brian K Do, Cassie A Ludwig, Andrea L Kossler, Prithvi Mruthyunjaya, Ehsan Rahimy
{"title":"克罗恩病合并眼部受累患者的肠道并发症、肠道外发病率和死亡率风险","authors":"Amer F Alsoudi, Karen M Wai, Euna Koo, Ryan A McConnell, Nathan H Pham, Brian K Do, Cassie A Ludwig, Andrea L Kossler, Prithvi Mruthyunjaya, Ehsan Rahimy","doi":"10.1080/09273948.2024.2413895","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Patients with Crohn's disease (CD) and subsequent ocular manifestations may have worse outcomes when compared to matched patients with CD without ocular disease.</p><p><strong>Methods: </strong>In this retrospective cohort study, an aggregated electronic health records research network, TriNetX (Cambridge, MA, USA), was used to identify patients diagnosed with CD stratified by the presence or absence of ocular involvement with at least 1 year of follow-up. Propensity score matching (PSM) was performed to control for baseline demographics and medical comorbidities.</p><p><strong>Results: </strong>Patients with CD with ocular disease showed a greater risk of undergoing bowel resections (RR: 2.06, 95% CI: 1.48-2.85, <i>p</i> < 0.001), developing other CD-related gastrointestinal complications (RR: 1.31, CI: 1.15-1.49, <i>p</i> < 0.001), or acquiring Clostridioides difficile infections (RR: 2.19, CI: 1.89-2.54, <i>p</i> < 0.001). Further, patients with CD with ocular sequelae had a greater risk of developing NASH (RR: 1.43, CI: 1.31-1.56, <i>p</i> < 0.001), CD-related nutrient deficiencies (RR: 1.38, CI: 1.29-1.49, <i>p</i> < 0.001), iron deficiency anemia (RR: 1.41, CI: 1.33-1.50, <i>p</i> < 0.001), CD-related dermatological disease (RR: 1.84, CI: 1.65-2.05, <i>p</i> < 0.001), osteoporosis (RR: 1.49, CI: 1.37-1.64, <i>p</i> < 0.001) and primary sclerosing cholangitis (RR: 1.63, CI: 1.11-2.38, <i>p</i> = 0.011). Among patients with CD with ocular involvement, there was an elevated risk of MI (RR: 1.36, CI: 1.14-1.63, <i>p</i> < 0.001), stroke (RR: 1.42, CI: 1.18-1.70, <i>p</i> < 0.001), VTE (RR: 1.37, CI: 1.22-1.54, <i>p</i> < 0.001), and sepsis (RR: 1.53, CI: 1.37-1.71, <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Patients who have CD and subsequent ocular involvement have an increased risk of local intestinal complications, extraintestinal morbidity, and cardiovascular complications when compared to patients with CD without ocular involvement.</p>","PeriodicalId":19406,"journal":{"name":"Ocular Immunology and Inflammation","volume":" ","pages":"1-8"},"PeriodicalIF":2.6000,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk of Intestinal Complications, Extraintestinal Morbidity, and Mortality in Patients with Crohn's Disease and Ocular Involvement.\",\"authors\":\"Amer F Alsoudi, Karen M Wai, Euna Koo, Ryan A McConnell, Nathan H Pham, Brian K Do, Cassie A Ludwig, Andrea L Kossler, Prithvi Mruthyunjaya, Ehsan Rahimy\",\"doi\":\"10.1080/09273948.2024.2413895\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Patients with Crohn's disease (CD) and subsequent ocular manifestations may have worse outcomes when compared to matched patients with CD without ocular disease.</p><p><strong>Methods: </strong>In this retrospective cohort study, an aggregated electronic health records research network, TriNetX (Cambridge, MA, USA), was used to identify patients diagnosed with CD stratified by the presence or absence of ocular involvement with at least 1 year of follow-up. Propensity score matching (PSM) was performed to control for baseline demographics and medical comorbidities.</p><p><strong>Results: </strong>Patients with CD with ocular disease showed a greater risk of undergoing bowel resections (RR: 2.06, 95% CI: 1.48-2.85, <i>p</i> < 0.001), developing other CD-related gastrointestinal complications (RR: 1.31, CI: 1.15-1.49, <i>p</i> < 0.001), or acquiring Clostridioides difficile infections (RR: 2.19, CI: 1.89-2.54, <i>p</i> < 0.001). Further, patients with CD with ocular sequelae had a greater risk of developing NASH (RR: 1.43, CI: 1.31-1.56, <i>p</i> < 0.001), CD-related nutrient deficiencies (RR: 1.38, CI: 1.29-1.49, <i>p</i> < 0.001), iron deficiency anemia (RR: 1.41, CI: 1.33-1.50, <i>p</i> < 0.001), CD-related dermatological disease (RR: 1.84, CI: 1.65-2.05, <i>p</i> < 0.001), osteoporosis (RR: 1.49, CI: 1.37-1.64, <i>p</i> < 0.001) and primary sclerosing cholangitis (RR: 1.63, CI: 1.11-2.38, <i>p</i> = 0.011). Among patients with CD with ocular involvement, there was an elevated risk of MI (RR: 1.36, CI: 1.14-1.63, <i>p</i> < 0.001), stroke (RR: 1.42, CI: 1.18-1.70, <i>p</i> < 0.001), VTE (RR: 1.37, CI: 1.22-1.54, <i>p</i> < 0.001), and sepsis (RR: 1.53, CI: 1.37-1.71, <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Patients who have CD and subsequent ocular involvement have an increased risk of local intestinal complications, extraintestinal morbidity, and cardiovascular complications when compared to patients with CD without ocular involvement.</p>\",\"PeriodicalId\":19406,\"journal\":{\"name\":\"Ocular Immunology and Inflammation\",\"volume\":\" \",\"pages\":\"1-8\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-10-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ocular Immunology and Inflammation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/09273948.2024.2413895\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Immunology and Inflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09273948.2024.2413895","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:与无眼部疾病的相匹配的克罗恩病患者相比,患有克罗恩病(CD)并随后出现眼部表现的患者的预后可能更差:在这项回顾性队列研究中,研究人员利用聚合的电子健康记录研究网络 TriNetX(美国马萨诸塞州剑桥市),根据是否存在眼部受累以及至少 1 年的随访时间,对确诊为 CD 的患者进行分层。进行倾向评分匹配(PSM)以控制基线人口统计学和医疗合并症:结果:伴有眼部疾病的 CD 患者接受肠切除术的风险更高(RR:2.06,95% CI:1.48-2.85,P P P P P P P = 0.011)。在眼部受累的 CD 患者中,发生心肌梗死的风险较高(RR:1.36,CI:1.14-1.63,P P P P P 结论:与没有眼部受累的 CD 患者相比,患有 CD 并继发眼部受累的患者发生局部肠道并发症、肠道外发病率和心血管并发症的风险更高。
Risk of Intestinal Complications, Extraintestinal Morbidity, and Mortality in Patients with Crohn's Disease and Ocular Involvement.
Purpose: Patients with Crohn's disease (CD) and subsequent ocular manifestations may have worse outcomes when compared to matched patients with CD without ocular disease.
Methods: In this retrospective cohort study, an aggregated electronic health records research network, TriNetX (Cambridge, MA, USA), was used to identify patients diagnosed with CD stratified by the presence or absence of ocular involvement with at least 1 year of follow-up. Propensity score matching (PSM) was performed to control for baseline demographics and medical comorbidities.
Results: Patients with CD with ocular disease showed a greater risk of undergoing bowel resections (RR: 2.06, 95% CI: 1.48-2.85, p < 0.001), developing other CD-related gastrointestinal complications (RR: 1.31, CI: 1.15-1.49, p < 0.001), or acquiring Clostridioides difficile infections (RR: 2.19, CI: 1.89-2.54, p < 0.001). Further, patients with CD with ocular sequelae had a greater risk of developing NASH (RR: 1.43, CI: 1.31-1.56, p < 0.001), CD-related nutrient deficiencies (RR: 1.38, CI: 1.29-1.49, p < 0.001), iron deficiency anemia (RR: 1.41, CI: 1.33-1.50, p < 0.001), CD-related dermatological disease (RR: 1.84, CI: 1.65-2.05, p < 0.001), osteoporosis (RR: 1.49, CI: 1.37-1.64, p < 0.001) and primary sclerosing cholangitis (RR: 1.63, CI: 1.11-2.38, p = 0.011). Among patients with CD with ocular involvement, there was an elevated risk of MI (RR: 1.36, CI: 1.14-1.63, p < 0.001), stroke (RR: 1.42, CI: 1.18-1.70, p < 0.001), VTE (RR: 1.37, CI: 1.22-1.54, p < 0.001), and sepsis (RR: 1.53, CI: 1.37-1.71, p < 0.001).
Conclusions: Patients who have CD and subsequent ocular involvement have an increased risk of local intestinal complications, extraintestinal morbidity, and cardiovascular complications when compared to patients with CD without ocular involvement.
期刊介绍:
Ocular Immunology & Inflammation ranks 18 out of 59 in the Ophthalmology Category.Ocular Immunology and Inflammation is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and vision scientists. Published bimonthly, the journal provides an international medium for basic and clinical research reports on the ocular inflammatory response and its control by the immune system. The journal publishes original research papers, case reports, reviews, letters to the editor, meeting abstracts, and invited editorials.